The objective of this study was to determine the cost-effectiveness of intra-arterial treatment within the 0 - to 6-hour window after intravenous tissue-type plasminogen activator within 0 - to 4.5-hour compared with intravenous tissue-type plasminogen activator alone , in the US setting and from a social perspective .